NYSEARCA:IHE

Ishares Us Pharmaceuticals Etf ETF News

etoro logo Buy IHE
*Your capital is at risk
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
UBS Group AG increased its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exch
Bank of America Corp DE lifted its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 61.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The
Johnson and Johnson's diversified business model will help JNJ stock weather any potential economic slowdown in the rest of the year, so investors can rest easy with the company's consistent dividends
Raymond James & Associates lowered its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 69.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The ins
First Republic Investment Management Inc. cut its position in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing wi
Ameritas Investment Company LLC boosted its stake in iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 21.9% during the 4th quarter, according to the company in its most recent filing with the Securiti
Advisor Group Inc. lessened its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 11.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owne
Envestnet Asset Management Inc. boosted its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 3.0% in the fourth quarter, according to its most recent disclosure with the SEC. The fi
Fmr LLC boosted its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 57.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities
Sector ETF report for PPH
First Allied Advisory Services Inc. lowered its stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 30.1% during the 4th quarter, according to its most recent Form 13F filing with the
Amarin stock has declined by nearly a quarter so far in 2020 on little news. That lower valuation makes AMRN intriguing.
Health insurance, hospitals and drug names all trade sharply lower following Bernie Sanders' convincing win in the Nevada caucuses (XLV -2.4%).Sanders supports "Medicare for All," which would
Aft Forsyth & Company Inc. purchased a new stake in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to the company in its most recent disclosure with the Secu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE